Can't see the buy side improving until Optiscan does update the market on the Know How agreement with The Mayo Clinic. You'd like to think there is a detailed project plan with goals, tasks, scope, deadlines, milestones and deliverables. In which case, regular updates could be given. There is virtually no information available for analysts (and punters) to review. Just the excitable announcement and the only really definitive statement I've found being "Formal detailed design work will commence in Q3 FY25, laying the foundation for prototype development". I always worry that they are running out of runway! In anyone knows anymore please feel free to share.
OIL Price at posting:
11.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)